Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-022010
Filing Date
2024-08-22
Accepted
2024-08-22 16:12:00
Documents
1
Period of Report
2024-08-20

Document Format Files

Seq Description Document Type Size
1 form4-08222024_080856.html 4  
1 form4-08222024_080856.xml 4 4310
  Complete submission text file 0001415889-24-022010.txt   5882
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTE BIOSCIENCES, INC. 1124 W. CARSON ST., MRL BLDG 3-320 TORRANCE CA 90502
Business Address
Eichenfield Lawrence (Reporting) CIK: 0001814892 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 241232131